Craft
Qiagen

Qiagen

Revenue

$2.3 B

FY, 2021

Market Capitalization

€10.5 B

2022-11-18

Qiagen Summary

Company summary

Overview
Qiagen is a company that provides a sample to insight solutions for molecular testing. Its products include sample and assay kits, polymerase chain reaction (PCR) instruments, gene reader next-generation sequencing (NGS) systems, analytical software, etc. The company serves molecular diagnostics, academia, pharmaceutical, and applied testing applications.
Type
Public
Status
Active
Founded
1984
HQ
Venlo, NL | view all locations
Website
https://www.qiagen.com
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key people

  • Thierry Bernard

    Thierry Bernard, Chief Executive Officer and Managing Director

  • Stephany Foster Spahr

    Stephany Foster Spahr, Senior Vice President, Head of Human Resources

  • Jonathan Sheldon

    Jonathan Sheldon, Senior Vice President & EVP, QIAGEN Digital Insights Business Area, Member of the Executive Committee

  • Phoebe Loh

    Phoebe Loh, Senior Director, Global Investor Relations

LocationsView all

40 locations detected

  • Venlo, LI HQ

    Netherlands

    Hulsterweg 82

  • Beverly, MA

    United States

    100 Cummings Center #407J

  • Germantown, MD

    United States

    19300 Germantown Rd

  • Redwood City, CA

    United States

    1001 Marshall St #200

  • Chadstone, VIC

    Australia

    1341 Dandenong Rd

  • Antwerpen, Vlaanderen

    Belgium

    Quellinstraat 49

and 34 others

Qiagen Financials

Summary financials

Revenue (Q3, 2022)
$499.6M
Gross profit (Q3, 2022)
$290.3M
Net income (Q3, 2022)
$82.4M
Cash (Q2, 2022)
$706.5M
EBIT (Q3, 2022)
$102.1M
Enterprise value
$11.5B

Blogs

Footer menu